1. The Lung Cancer Substudy (LCS). 1994-1999
2. A Multicenter Evaluation of the Effects of Zyban versus Placebo in a population of smokers with COPD. Glaxo-Welcome 1998-2000
3. A Double-Blind Randomized, Placebo and Active Controlled Multicenter, Parallel Group, Dose Ranging Study of L753099 in Patients with COPD. Merk & Co. 2000
4. A Randomized, double-blind, parallel group trial assessing the efficacy and safety in subjects at least 12 years of age with chronic asthma currently treated with inhaled corticosteroids. Glaxo-Welcome, Inc. 2000
5. Efficacy and safety of MF-DPI in the Treatment of Patients with Chronic Obstructive Pulmonary Disease. Schering Plough. 2001-2002
6. A randomized, 24 week, double-blind, placebo controlled, parallel group study to evaluate the efficacy and tolerability of Ariflo (15 mg BID) in patients with Chronic Obstructive Pulmonary Disease. Glaxo-Smithkline. 2001-2002
7. A phase IIIB, multicenter, randomized, double-blind, placebo-controlled, parallel group trial assesing the rate of decline of lung function with Titropium 18 mcg inhalation capsule once daily in patients with chronic obstrucive pulmonary disease
8. A randomized, double-blind, placebo-controlled phase 3 study of the safety and efficacy of Pirfenidone in patients with Idiopathic Pulmonary Fibrosis
9. GIPF-007: Randomized, double-blind, placebo-controlled, phase 3 study of the safety and efficacy of interferon gamma-1b in patients with Idiopathic Pulmonary Fibrosis
Physicians
